A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
Status:
Terminated
Trial end date:
2020-05-12
Target enrollment:
Participant gender:
Summary
This is a phase Ib,single arm,open label study evaluating the safety and efficacy of
CT053PTSA in patients with advanced and metastatic renal cell cancer who have progressed from
previous treatment